Skip to main content
Erschienen in: Pediatric Cardiology 1/2013

01.01.2013 | Original Article

The Fate and Observed Management of Giant Coronary Artery Aneurysms Secondary to Kawasaki Disease in the Province of Quebec: The Complete Series Since 1976

verfasst von: Ariane McNeal-Davidson, Anne Fournier, Rosie Scuccimarri, Adrian Dancea, Christine Houde, Marc Bellavance, Nagib Dahdah

Erschienen in: Pediatric Cardiology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Most population-based series reporting on the coronary artery complications after Kawasaki disease (KD) originate from Japan. This study aimed to describe the complete series of KD patients from the province of Quebec in Canada, a predominantly Caucasian population. This retrospective case series was conducted by the Quebec Kawasaki Disease Registry, a multi-institutional collaboration reviewing 89.8 % of all KD cases identified by the Ministry of Health records of hospitalization for KD from the first recognized case in 1976 until 2008. This report describes the course of 38 patients (95 % Caucasians) with a diagnosis of giant coronary artery aneurysms, which represent 1.9 % of all reviewed cases and 26.2 % of those with a coronary aneurysm 5 mm or larger. The age at diagnosis was 5.52 ± 4.04 years, and the follow-up period was 9.26 ± 6.9 years. The KD diagnosis was retrospective at autopsy in two cases and via echocardiography in four cases. The overall freedom from coronary thrombi, coronary intervention, or death was respectively 63.9, 67.5, and 85.1 %. Five deaths occurred as follows: 21 days after onset of fever (2 cases), 1.8 months after onset of fever (1 case), 1 year after retrospectively presumed but previously undiagnosed KD (1 case), and 5.7 years after a KD diagnosis (1 case of sudden cardiac death). Percutaneous transluminal coronary revascularization was attempted in four cases (1 requiring cardiac transplantation), and two other cases underwent primary bypass graft surgery. Whereas this study investigated cases of KD with severe coronary sequelae in the Province of Quebec, larger collaborative studies should be conducted for further understanding of the disease in predominantly non-Asian populations.
Literatur
1.
Zurück zum Zitat Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694PubMedCrossRef Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694PubMedCrossRef
2.
Zurück zum Zitat Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, Baba K, Matsushima M, Hamaoka K, Tomita H, Ishii M, Kato H (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181–186PubMedCrossRef Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, Baba K, Matsushima M, Hamaoka K, Tomita H, Ishii M, Kato H (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181–186PubMedCrossRef
3.
Zurück zum Zitat Alloul S, Dahdah N, Miró J (2009) Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal. Pediatr Cardiol 30:188–190PubMedCrossRef Alloul S, Dahdah N, Miró J (2009) Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal. Pediatr Cardiol 30:188–190PubMedCrossRef
4.
Zurück zum Zitat Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL (2000) Kawasaki disease: a brief history. Pediatrics 106:e27PubMedCrossRef Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL (2000) Kawasaki disease: a brief history. Pediatrics 106:e27PubMedCrossRef
5.
Zurück zum Zitat Dahdah NS, Fournier A, Jaeggi E, van Doesburg NH, Lambert R, Dionne N, Sauvé C (1999) Segmental myocardial contractility versus perfusion in Kawasaki disease with coronary arterial aneurysm. Am J Cardiol 83:48–51PubMedCrossRef Dahdah NS, Fournier A, Jaeggi E, van Doesburg NH, Lambert R, Dionne N, Sauvé C (1999) Segmental myocardial contractility versus perfusion in Kawasaki disease with coronary arterial aneurysm. Am J Cardiol 83:48–51PubMedCrossRef
6.
Zurück zum Zitat Dahdah N, Ibrahim R, Cannon L (2007) First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter. Pediatr Cardiol 28:193–389CrossRef Dahdah N, Ibrahim R, Cannon L (2007) First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter. Pediatr Cardiol 28:193–389CrossRef
7.
Zurück zum Zitat Dallaire F, Dahdah N (2011) New equations and a critical appraisal of coronary artery z-scores in healthy children. J Am Soc Echocardiogr 24:60–74PubMedCrossRef Dallaire F, Dahdah N (2011) New equations and a critical appraisal of coronary artery z-scores in healthy children. J Am Soc Echocardiogr 24:60–74PubMedCrossRef
8.
Zurück zum Zitat Fujiwara H, Hmashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100–107PubMed Fujiwara H, Hmashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100–107PubMed
9.
Zurück zum Zitat Fujiwara T, Fujiwara H, Hamashima H (1987) Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res 250:519–520PubMed Fujiwara T, Fujiwara H, Hamashima H (1987) Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res 250:519–520PubMed
10.
Zurück zum Zitat Fulton DR, Newburger JW (2000) Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2:324–329PubMedCrossRef Fulton DR, Newburger JW (2000) Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2:324–329PubMedCrossRef
11.
Zurück zum Zitat Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRef Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRef
12.
Zurück zum Zitat Hayasaka S, Nakamura Y, Yashiro M, Uehara R, Oki I, Tajimi M, Ojima T, Terai M, Yanagawa H (2003) Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years. J Epidemiol 13:246–250PubMedCrossRef Hayasaka S, Nakamura Y, Yashiro M, Uehara R, Oki I, Tajimi M, Ojima T, Terai M, Yanagawa H (2003) Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years. J Epidemiol 13:246–250PubMedCrossRef
13.
Zurück zum Zitat Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB (2003) Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495–501PubMedCrossRef Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB (2003) Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495–501PubMedCrossRef
14.
Zurück zum Zitat Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194–197PubMed Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194–197PubMed
15.
Zurück zum Zitat Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108:923–927PubMedCrossRef Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108:923–927PubMedCrossRef
16.
Zurück zum Zitat Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequence of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMedCrossRef Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequence of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMedCrossRef
17.
Zurück zum Zitat Lapierre C, Bitsch A, Guérin R, Garel L, Miró J, Dahdah N (2010) Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification. Pediatr Cardiol 31:56–61PubMedCrossRef Lapierre C, Bitsch A, Guérin R, Garel L, Miró J, Dahdah N (2010) Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification. Pediatr Cardiol 31:56–61PubMedCrossRef
18.
Zurück zum Zitat Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS (2005) Long-term outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol 32:928–934PubMed Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS (2005) Long-term outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol 32:928–934PubMed
19.
Zurück zum Zitat Manlhiot C, Brandão LR, Somji Z, Chesney AL, MacDonald C, Gurofsky RC, Sabharwal T, Chahal N, McCrindle BW (2010) Long-term anticoagulation in Kawasaki disease: initial use of low-molecular-weight heparin is a viable option for patients with severe coronary artery abnormalities. Pediatr Cardiol 31:834–842PubMedCrossRef Manlhiot C, Brandão LR, Somji Z, Chesney AL, MacDonald C, Gurofsky RC, Sabharwal T, Chahal N, McCrindle BW (2010) Long-term anticoagulation in Kawasaki disease: initial use of low-molecular-weight heparin is a viable option for patients with severe coronary artery abnormalities. Pediatr Cardiol 31:834–842PubMedCrossRef
20.
Zurück zum Zitat Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249PubMedCrossRef Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249PubMedCrossRef
21.
Zurück zum Zitat McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW (2007) Pediatric Heart Network Investigators Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW (2007) Pediatric Heart Network Investigators Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef
22.
Zurück zum Zitat Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H, Kawasaki T (2005) Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae? Acta Paediatr 94:429–434PubMedCrossRef Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H, Kawasaki T (2005) Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae? Acta Paediatr 94:429–434PubMedCrossRef
23.
Zurück zum Zitat Nakano H, Ueda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56:846–851PubMedCrossRef Nakano H, Ueda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56:846–851PubMedCrossRef
24.
Zurück zum Zitat Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771PubMedCrossRef Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771PubMedCrossRef
25.
Zurück zum Zitat Olivieri L, Arling B, Friberg M, Sable C (2009) Coronary artery z-score regression equations and calculators derived from a large heterogeneous population of children undergoing echocadiography. J Am Soc Echocardiogr 22:159–164PubMedCrossRef Olivieri L, Arling B, Friberg M, Sable C (2009) Coronary artery z-score regression equations and calculators derived from a large heterogeneous population of children undergoing echocadiography. J Am Soc Echocardiogr 22:159–164PubMedCrossRef
26.
Zurück zum Zitat Pantos I, Patatoukas G, Katritsis DG, Efstathopoulos E (2009) Patient radiation doses in interventional cardiology procedures. Curr Cardiol Rev 5:1–11PubMedCrossRef Pantos I, Patatoukas G, Katritsis DG, Efstathopoulos E (2009) Patient radiation doses in interventional cardiology procedures. Curr Cardiol Rev 5:1–11PubMedCrossRef
27.
Zurück zum Zitat Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, Japan Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, Japan
28.
Zurück zum Zitat Sasaguri Y, Kato H (1982) Regression of aneurysms in Kawasaki disease: a pathological study? J Pediatr 100:225–231PubMedCrossRef Sasaguri Y, Kato H (1982) Regression of aneurysms in Kawasaki disease: a pathological study? J Pediatr 100:225–231PubMedCrossRef
29.
Zurück zum Zitat Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, Kudo Y, Itoh S, Ishii H, Ueno T, Tashiro T, Nobuyoshi M, Kato H, Matsuishi T (2011) Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 123:1836–4218PubMedCrossRef Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, Kudo Y, Itoh S, Ishii H, Ueno T, Tashiro T, Nobuyoshi M, Kato H, Matsuishi T (2011) Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 123:1836–4218PubMedCrossRef
30.
Zurück zum Zitat Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H (2008) Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 29:398–401PubMedCrossRef Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H (2008) Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 29:398–401PubMedCrossRef
31.
Zurück zum Zitat Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N (1992) Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 121:684–688PubMedCrossRef Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N (1992) Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 121:684–688PubMedCrossRef
32.
Zurück zum Zitat Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394PubMedCrossRef Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394PubMedCrossRef
33.
Zurück zum Zitat Tanaka N, Naoe S, Masuda H, Ueno T (1986) Pathological study of sequelae of Kawasaki disease (MCLS), with specific reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513–1527PubMed Tanaka N, Naoe S, Masuda H, Ueno T (1986) Pathological study of sequelae of Kawasaki disease (MCLS), with specific reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513–1527PubMed
34.
Zurück zum Zitat Tatara K, Kusakawa S, Itoh K, Honma S, Hashimoto K, Kazuma N, Lee K, Asai T, Murata M (1991) Collateral circulation in Kawasaki disease with coronary occlusion or severe stenosis. Am Heart J 121:797–802PubMedCrossRef Tatara K, Kusakawa S, Itoh K, Honma S, Hashimoto K, Kazuma N, Lee K, Asai T, Murata M (1991) Collateral circulation in Kawasaki disease with coronary occlusion or severe stenosis. Am Heart J 121:797–802PubMedCrossRef
35.
Zurück zum Zitat Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S (2005) Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73–79PubMedCrossRef Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S (2005) Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73–79PubMedCrossRef
36.
Zurück zum Zitat Uehara R, Nakamura Y, Yanagawa H (2005) Epidemiology of Kawasaki disease in Japan. Jpn Med Assoc J 48:183–193 Uehara R, Nakamura Y, Yanagawa H (2005) Epidemiology of Kawasaki disease in Japan. Jpn Med Assoc J 48:183–193
37.
Zurück zum Zitat Velasco-Sanchez D, Lambert R, Turpin S, Laforge S, Fournier A, Lapierre C, Dahdah N (2012) Right ventricle myocardial perfusion scintigraphy: feasibility and expected values in children. Pediatr Cardiol 33:295–301PubMedCrossRef Velasco-Sanchez D, Lambert R, Turpin S, Laforge S, Fournier A, Lapierre C, Dahdah N (2012) Right ventricle myocardial perfusion scintigraphy: feasibility and expected values in children. Pediatr Cardiol 33:295–301PubMedCrossRef
38.
Zurück zum Zitat Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H (1998) Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 31:1074–1080PubMedCrossRef Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H (1998) Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 31:1074–1080PubMedCrossRef
Metadaten
Titel
The Fate and Observed Management of Giant Coronary Artery Aneurysms Secondary to Kawasaki Disease in the Province of Quebec: The Complete Series Since 1976
verfasst von
Ariane McNeal-Davidson
Anne Fournier
Rosie Scuccimarri
Adrian Dancea
Christine Houde
Marc Bellavance
Nagib Dahdah
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 1/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0409-2

Weitere Artikel der Ausgabe 1/2013

Pediatric Cardiology 1/2013 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.